Sarepta Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. My name is Gena Wang. I'm biotech analyst at Barclays. Welcome to our second virtual global healthcare conference. First, I wish everyone stay healthy. And I would like to thank all the participants: investors, companies, and also, particularly our event team and the corporate access team, who made this virtual health care conference possible.
With that, I would like to introduce our next presenting company, Sarepta. With us today, we have Doug Ingram, President and Chief Executive Officer. We have Gilmore O'Neill, our Chief Medical Officer. And also, we have Ian Estepan, Chief Financial Officer.
With that, I hand over to you, Doug, to give a brief overview of the company, and then we jump into Q&A.
And I'll be very brief. Gena, first, thank you for having us today. We're excited to talk about our various programs. As you know, for those who may be less familiar with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
